首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

全球筆針市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

市場調查報告書

商品編碼

1306533

全球筆針市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global Pen Needles Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年06月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

據預測，全球筆形針市場需求將從2022年的21.9億美元成長到2030年的55.9億美元，2023-2030年的複合年成長率為12.4%。

筆形針是一種小型拋棄式醫療器械，用於將胰島素注射到皮下組織，以治療糖尿病。它們專門設計用於胰島素筆，胰島素筆是常用的胰島素注射設備。它由一根細長的空心針頭和一個塑膠轂組成，塑膠轂與胰島素筆相連。它們有各種長度和規格，以滿足不同患者的需求。

市場動態：

隨著越來越多的人被診斷出患有糖尿病並需要使用胰島素給藥系統，全球糖尿病患病率的上升是一個重要的驅動因素。胰島素筆針為胰島素給藥提供了方便、準確的方法，滿足了糖尿病患者的需求。胰島素筆的應用日益廣泛是另一個驅動因素。胰島素筆因其使用方便、便於攜帶和隱蔽而廣受歡迎。筆形針是專為胰島素筆設計的，隨著胰島素筆應用的增加，對這些針的需求也在增加。技術進步對市場成長起著至關重要的作用。製造商不斷改進設計，以提高患者的舒適度，如超薄針頭、潤滑表面和改進的針尖幾何形狀。這些創新旨在將疼痛降至最低，並提供更好的整體胰島素注射體驗。患者對自行注射胰島素的偏好正在增加，從而促進了對這類產品的需求。許多醣尿病患者更願意自己控制治療，減少對醫護人員的依賴。筆形針提供了一種方便用戶使用和方便的自我給藥選擇，支持了患者在糖尿病護理方面的獨立願望。政府在糖尿病管理方面的計劃和支持也推動了市場的發展。各國政府和醫療機構正在積極提高對糖尿病的認知，促進糖尿病的早期診斷和治療，這反過來又增加了對作為胰島素治療重要組成部分的筆形針的需求。

研究涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構，評估全球競爭吸引力。此外，這些工具還對全球筆針市場的各個細分市場進行了全面評估。筆形針行業的成長和趨勢為本研究提供了整體方法。

區域分析：

該部分涵蓋了區域前景，突出了北美、歐洲、亞太、拉丁美洲、中東和非洲地區筆形針市場的當前和未來需求。此外，該部分還重點分析了所有主要地區各個應用領域的需求、估計和預測。

該研究還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。筆形針市場的主要參與者包括Becton, Dickinson and Company（美國）、Novo Nordisk A/S（丹麥）、Ypsomed Holding AG（瑞士）、B. Braun Melsungen AG（德國）、Owen Mumford（英國）、Terumo Corporation（日本）、HTL-STREFA（波蘭）、UltiMed（美國）、Artsana Group（義大利）、Allison Medical（美國）。這部分包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求，請聯繫我們。我們的研究團隊可以根據您的需求提供客製化服務。

地區前景
產品介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區細分市場銷售分析
- 亞太地區各國銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東及非洲地區銷售分析
- 中東及非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東及非洲其他地區銷售分析

第九章筆針企業競爭格局分析

筆形針市場競爭格局
夥伴關係/合作/協議
合併與收購
新產品發布
其他發展

第10章: 公司簡介

公司佔有率分析
市場集中率
Becton
- 公司概況
- 公司收入
- 公司產品
- 近期發展
Dickinson and Company (US)
- 公司概況
- 公司收入
- 產品
- 近期發展
Novo Nordisk A/S (Denmark)
- 公司概況
- 公司收入
- 產品
- 近期發展
Ypsomed Holding AG (Switzerland)
- 公司概況
- 公司收入
- 產品
- 近期發展
B. Braun Melsungen AG (Germany)
- 公司概況
- 公司收入
- 產品
- 近期發展
Owen Mumford (UK)
- 公司概況
- 公司收入
- 產品
- 近期發展
Terumo Corporation (Japan)
- 公司概況
- 公司收入
- 產品
- 近期發展
HTL-STREFA (Poland)
- 公司概況
- 公司收入
- 產品
- 近期發展
UltiMed (US)
- 公司概況
- 公司收入
- 產品
- 近期發展
Artsana Group (Italy)
- 公司概況
- 公司收入
- 產品
- 近期發展
Allison Medical (US)
- 公司概況
- 公司收入
- 產品
- 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

簡介目錄圖表

Product Code: VMR112111528

The global demand for Pen Needles Market is presumed to reach the market size of nearly USD 5.59 BN by 2030 from USD 2.19 BN in 2022 with a CAGR of 12.4% under the study period 2023 - 2030.

Pen needles are small, disposable medical devices used for injecting insulin into the subcutaneous tissue for the management of diabetes. They are specifically designed for use with insulin pens, which are popular devices for administering insulin. It consists of a thin, hollow needle attached to a plastic hub, which connects to the insulin pen. They come in various lengths and gauges to accommodate different patient needs.

MARKET DYNAMICS:

The rising prevalence of diabetes worldwide is a significant driver, as more individuals are diagnosed with the condition and require insulin delivery systems. Pen needles offer a convenient and accurate method for insulin administration, catering to the needs of diabetic patients. The increasing adoption of insulin pens is another driving factor. Insulin pens have become popular due to their ease of use, portability, and discreetness. Pen needles are specifically designed for insulin pens, and as their adoption increases, so does the demand for these needles. Advancements in its technology play a vital role in market growth. Manufacturers are continuously improving designs to enhance patient comfort with features like ultra-thin needles, lubricated surfaces, and improved needle-tip geometries. These innovations aim to minimise pain and provide a better overall insulin injection experience. Patient preference for self-administration of insulin injections is increasing, contributing to the demand for these products. Many individuals with diabetes prefer to have more control over their treatment and rely less on healthcare professionals. Pen needles offer a user-friendly and convenient option for self-administration, supporting patients' desire for independence in their diabetes care. Government initiatives and support in diabetes management also drive the market. Governments and healthcare organisations are actively promoting awareness, early diagnosis, and treatment options for diabetes, which in turn increases the demand for pen needles as an essential component of insulin therapy.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pen needles. The growth and trends of pen needles industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the pen needles market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Standard Pen Needles
Safety Pen Needles

By Length

4Mm
5Mm
6Mm
8Mm
10Mm
12Mm

By Therapy

Insulin Therapy
Glucagon-Like Peptide-1 (GLP-1) Therapy
Growth Hormone Therapy
Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Pen Needles market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pen needles market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), HTL-STREFA (Poland), UltiMed (US), Artsana Group (Italy), Allison Medical (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

1 . PREFACE

1.1. Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PEN NEEDLES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Length
- 3.7.3 Market Attractiveness Analysis By Therapy
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Standard Pen Needles Historic and Forecast Sales by Regions
5.5 Safety Pen Needles Historic and Forecast Sales by Regions

6 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY LENGTH

6.1 Overview by Length
6.2 Historical and Forecast Data
6.3 Analysis by Length
6.4 4mm Historic and Forecast Sales by Regions
6.5 5mm Historic and Forecast Sales by Regions
6.6 6mm Historic and Forecast Sales by Regions
6.7 8mm Historic and Forecast Sales by Regions
6.8 10mm Historic and Forecast Sales by Regions
6.9 12mm Historic and Forecast Sales by Regions

7 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY THERAPY

7.1 Overview by Therapy
7.2 Historical and Forecast Data
7.3 Analysis by Therapy
7.4 Insulin Therapy Historic and Forecast Sales by Regions
7.5 Glucagon-like Peptide-1 (GLP-1) Therapy Historic and Forecast Sales by Regions
7.6 Growth Hormone Therapy Historic and Forecast Sales by Regions
7.7 Other Historic and Forecast Sales by Regions

8 . GLOBAL PEN NEEDLES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PEN NEEDLES COMPANIES

9.1. Pen Needles Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PEN NEEDLES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Becton
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Dickinson and Company (US)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Novo Nordisk A/S (Denmark)
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Ypsomed Holding AG (Switzerland)
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. B. Braun Melsungen AG (Germany)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Owen Mumford (UK)
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Terumo Corporation (Japan)
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. HTL-STREFA (Poland)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. UltiMed (US)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Artsana Group (Italy)
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Allison Medical (US)
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments